Division of Hospital Medicine, Department of Internal Medicine, Northcentral Baptist Medical Center, San Antonio, TX, USA.
Section of Vascular Surgery and Endovascular Therapy, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, México.
Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):48S-55S. doi: 10.1177/1076029618812954. Epub 2018 Nov 19.
Pulmonary embolism represents the third most common cause of cardiovascular death in the United States. Reperfusion therapeutic strategies such as systemic thrombolysis, catheter directed therapies, surgical pulmonary embolectomy, and cardiopulmonary support devices are currently available for patients with high- and intermediate-high-risk pulmonary embolism. However, deciding on optimal therapy may be challenging. Pulmonary embolism response teams have been designed to facilitate multidisciplinary decision-making with the goal to improve quality of care for complex cases with pulmonary embolism. Herein, we discuss the current role and strategies on how to leverage the strengths from pulmonary embolism response teams, its possible worldwide adoption, and implementation to improve survival and change the paradigm in the care of a potentially deadly disease.
肺栓塞是美国心血管死亡的第三大常见原因。目前，对于高危和中高危肺栓塞患者，可采用再灌注治疗策略，如全身溶栓、导管定向治疗、肺动脉血栓切除术和心肺支持设备。然而，选择最佳治疗方法可能具有挑战性。肺栓塞反应团队旨在促进多学科决策，以提高肺栓塞复杂病例的护理质量。本文讨论了肺栓塞反应团队的当前作用和策略，以及如何利用其优势，在全球范围内推广应用，以提高生存率并改变潜在致命疾病的治疗模式。
